APO Research

APO RESEARCH · REPORT

Veterinary API Manufacturing

Selected research

Market Outlook & Growth Opportunities

Global Veterinary API Manufacturing Market Outlook and Growth Opportunities 2026

Market perspective

The global Veterinary API Manufacturing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Veterinary API Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary API Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary API Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Veterinary API Manufacturing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Veterinary API Manufacturing market include Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Jiangsu Lingyun Pharmaceutical Co., Ltd., SUANFARMA, Ofichem Group, NGL Fine-Chem Ltd., Menadiona, FIS - Fabbrica Italiana Sintetici S.p.A, Excel Industries Ltd. and Alivira Animal Health Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Veterinary API Manufacturing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary API Manufacturing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary API Manufacturing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Veterinary API Manufacturing market.

Veterinary API Manufacturing Segment by Company

Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.

Jiangsu Lingyun Pharmaceutical Co., Ltd.

SUANFARMA

Ofichem Group

NGL Fine-Chem Ltd.

Menadiona

FIS - Fabbrica Italiana Sintetici S.p.A

Excel Industries Ltd.

Alivira Animal Health Ltd.

Afton Pharma

Veterinary API Manufacturing Segment by Type

NSAIDs

Anti-infectives

Antiparasitic

Biologics

Vaccines

Others

Veterinary API Manufacturing Segment by Application

In House

Contract Outsourcing

Veterinary API Manufacturing Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Veterinary API Manufacturing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Veterinary API Manufacturing key companies, revenue, market share, and recent developments.

3. To split the Veterinary API Manufacturing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Veterinary API Manufacturing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary API Manufacturing significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary API Manufacturing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary API Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary API Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary API Manufacturing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary API Manufacturing industry.

Chapter 3: Detailed analysis of Veterinary API Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Veterinary API Manufacturing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Veterinary API Manufacturing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary API Manufacturing Industry Trends Table 2. Veterinary API Manufacturing Industry Drivers Table 3. Veterinary API Manufacturing Industry Opportunities and Challenges Table 4. Veterinary API Manufacturing Industry Restraints Table 5. Global Veterinary API Manufacturing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary API Manufacturing Revenue Share by Company (2021-2026) Table 7. Global Veterinary API Manufacturing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Veterinary API Manufacturing Key Company Manufacturing Base & Headquarters Table 9. Global Veterinary API Manufacturing Company, Product Type & Application Table 10. Global Veterinary API Manufacturing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Veterinary API Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of NSAIDs Table 15. Significant Companies of Anti-infectives Table 16. Significant Companies of Antiparasitic Table 17. Significant Companies of Biologics Table 18. Significant Companies of Vaccines Table 19. Significant Companies of Others Table 20. Global Veterinary API Manufacturing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Veterinary API Manufacturing Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Veterinary API Manufacturing Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Veterinary API Manufacturing Sales Value Share by Type (2021-2026) Table 24. Global Veterinary API Manufacturing Sales Value Share by Type (2027-2032) Table 25. Significant Companies of In House Table 26. Significant Companies of Contract Outsourcing Table 27. Global Veterinary API Manufacturing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Veterinary API Manufacturing Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Veterinary API Manufacturing Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Veterinary API Manufacturing Sales Value Share by Application (2021-2026) Table 31. Global Veterinary API Manufacturing Sales Value Share by Application (2027-2032) Table 32. Global Veterinary API Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Veterinary API Manufacturing Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Veterinary API Manufacturing Sales Value Share by Region (2021-2026) Table 35. Global Veterinary API Manufacturing Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Veterinary API Manufacturing Sales Value Share by Region (2027-2032) Table 37. Global Veterinary API Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Veterinary API Manufacturing Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Veterinary API Manufacturing Sales Value Market Share by Country (2021-2026) Table 40. Global Veterinary API Manufacturing Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Veterinary API Manufacturing Sales Value Market Share by Country (2027-2032) Table 42. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Company Information Table 43. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Business Overview Table 44. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Veterinary API Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Veterinary API Manufacturing Product Portfolio Table 46. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Recent Development Table 47. Jiangsu Lingyun Pharmaceutical Co., Ltd. Company Information Table 48. Jiangsu Lingyun Pharmaceutical Co., Ltd. Business Overview Table 49. Jiangsu Lingyun Pharmaceutical Co., Ltd. Veterinary API Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Jiangsu Lingyun Pharmaceutical Co., Ltd. Veterinary API Manufacturing Product Portfolio Table 51. Jiangsu Lingyun Pharmaceutical Co., Ltd. Recent Development Table 52. SUANFARMA Company Information Table 53. SUANFARMA Business Overview Table 54. SUANFARMA Veterinary API Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. SUANFARMA Veterinary API Manufacturing Product Portfolio Table 56. SUANFARMA Recent Development Table 57. Ofichem Group Company Information Table 58. Ofichem Group Business Overview Table 59. Ofichem Group Veterinary API Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Ofichem Group Veterinary API Manufacturing Product Portfolio Table 61. Ofichem Group Recent Development Table 62. NGL Fine-Chem Ltd. Company Information Table 63. NGL Fine-Chem Ltd. Business Overview Table 64. NGL Fine-Chem Ltd. Veterinary API Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. NGL Fine-Chem Ltd. Veterinary API Manufacturing Product Portfolio Table 66. NGL Fine-Chem Ltd. Recent Development Table 67. Menadiona Company Information Table 68. Menadiona Business Overview Table 69. Menadiona Veterinary API Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Menadiona Veterinary API Manufacturing Product Portfolio Table 71. Menadiona Recent Development Table 72. FIS - Fabbrica Italiana Sintetici S.p.A Company Information Table 73. FIS - Fabbrica Italiana Sintetici S.p.A Business Overview Table 74. FIS - Fabbrica Italiana Sintetici S.p.A Veterinary API Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. FIS - Fabbrica Italiana Sintetici S.p.A Veterinary API Manufacturing Product Portfolio Table 76. FIS - Fabbrica Italiana Sintetici S.p.A Recent Development Table 77. Excel Industries Ltd. Company Information Table 78. Excel Industries Ltd. Business Overview Table 79. Excel Industries Ltd. Veterinary API Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Excel Industries Ltd. Veterinary API Manufacturing Product Portfolio Table 81. Excel Industries Ltd. Recent Development Table 82. Alivira Animal Health Ltd. Company Information Table 83. Alivira Animal Health Ltd. Business Overview Table 84. Alivira Animal Health Ltd. Veterinary API Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Alivira Animal Health Ltd. Veterinary API Manufacturing Product Portfolio Table 86. Alivira Animal Health Ltd. Recent Development Table 87. Afton Pharma Company Information Table 88. Afton Pharma Business Overview Table 89. Afton Pharma Veterinary API Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Afton Pharma Veterinary API Manufacturing Product Portfolio Table 91. Afton Pharma Recent Development Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Veterinary API Manufacturing Product Image Figure 2. Global Veterinary API Manufacturing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary API Manufacturing Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary API Manufacturing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. NSAIDs Image Figure 8. Anti-infectives Image Figure 9. Antiparasitic Image Figure 10. Biologics Image Figure 11. Vaccines Image Figure 12. Others Image Figure 13. Global Veterinary API Manufacturing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Veterinary API Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Veterinary API Manufacturing Sales Value Share by Type (2021-2032) Figure 16. In House Image Figure 17. Contract Outsourcing Image Figure 18. Global Veterinary API Manufacturing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Veterinary API Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Veterinary API Manufacturing Sales Value Share by Application (2021-2032) Figure 21. Global Veterinary API Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Veterinary API Manufacturing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Veterinary API Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 24. North America Veterinary API Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Veterinary API Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Veterinary API Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Veterinary API Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Veterinary API Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Veterinary API Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 30. South America Veterinary API Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Veterinary API Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Veterinary API Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Veterinary API Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • NSAIDs
  • Anti-infectives
  • Antiparasitic
  • Biologics
  • Vaccines
  • Others
Applications
  • In House
  • Contract Outsourcing
Companies covered
  • Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
  • Jiangsu Lingyun Pharmaceutical Co., Ltd.
  • SUANFARMA
  • Ofichem Group
  • NGL Fine-Chem Ltd.
  • Menadiona
  • FIS - Fabbrica Italiana Sintetici S.p.A
  • Excel Industries Ltd.
  • Alivira Animal Health Ltd.
  • Afton Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Veterinary API Manufacturing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Veterinary API Manufacturing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Veterinary API Manufacturing Market Dynamics
  1. 2.1 Veterinary API Manufacturing Industry Trends
  2. 2.2 Veterinary API Manufacturing Industry Drivers
  3. 2.3 Veterinary API Manufacturing Industry Opportunities and Challenges
  4. 2.4 Veterinary API Manufacturing Industry Restraints
3 Veterinary API Manufacturing Market by Company
  1. 3.1 Global Veterinary API Manufacturing Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary API Manufacturing Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary API Manufacturing Company Ranking (2024-2026)
  4. 3.4 Global Veterinary API Manufacturing Company Manufacturing Base and Headquarters
  5. 3.5 Global Veterinary API Manufacturing Company Product Type and Application
  6. 3.6 Global Veterinary API Manufacturing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Veterinary API Manufacturing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Veterinary API Manufacturing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Veterinary API Manufacturing Market by Type
  1. 4.1 Veterinary API Manufacturing Type Introduction
  2. 4.1.1 NSAIDs
  3. 4.1.2 Anti-infectives
  4. 4.1.3 Antiparasitic
  5. 4.1.4 Biologics
  6. 4.1.5 Vaccines
  7. 4.1.6 Others
  8. 4.2 Global Veterinary API Manufacturing Sales Value by Type
  9. 4.2.1 Global Veterinary API Manufacturing Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Veterinary API Manufacturing Sales Value by Type (2021-2032)
  11. 4.2.3 Global Veterinary API Manufacturing Sales Value Share by Type (2021-2032)
5 Veterinary API Manufacturing Market by Application
  1. 5.1 Veterinary API Manufacturing Application Introduction
  2. 5.1.1 In House
  3. 5.1.2 Contract Outsourcing
  4. 5.2 Global Veterinary API Manufacturing Sales Value by Application
  5. 5.2.1 Global Veterinary API Manufacturing Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Veterinary API Manufacturing Sales Value by Application (2021-2032)
  7. 5.2.3 Global Veterinary API Manufacturing Sales Value Share by Application (2021-2032)
6 Veterinary API Manufacturing Regional Value Analysis
  1. 6.1 Global Veterinary API Manufacturing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary API Manufacturing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Veterinary API Manufacturing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Veterinary API Manufacturing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Veterinary API Manufacturing Sales Value (2021-2032)
  7. 6.3.2 North America Veterinary API Manufacturing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Veterinary API Manufacturing Sales Value (2021-2032)
  10. 6.4.2 Europe Veterinary API Manufacturing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Veterinary API Manufacturing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Veterinary API Manufacturing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Veterinary API Manufacturing Sales Value (2021-2032)
  16. 6.6.2 South America Veterinary API Manufacturing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Veterinary API Manufacturing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Veterinary API Manufacturing Sales Value Share by Country, 2025 VS 2032
7 Veterinary API Manufacturing Country-level Value Analysis
  1. 7.1 Global Veterinary API Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary API Manufacturing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Veterinary API Manufacturing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Veterinary API Manufacturing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Veterinary API Manufacturing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Veterinary API Manufacturing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Veterinary API Manufacturing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
  2. 8.1.1 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Company Information
  3. 8.1.2 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Business Overview
  4. 8.1.3 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Veterinary API Manufacturing Product Portfolio
  6. 8.1.5 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Recent Developments
  7. 8.2 Jiangsu Lingyun Pharmaceutical Co., Ltd.
  8. 8.2.1 Jiangsu Lingyun Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Jiangsu Lingyun Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Jiangsu Lingyun Pharmaceutical Co., Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Lingyun Pharmaceutical Co., Ltd. Veterinary API Manufacturing Product Portfolio
  12. 8.2.5 Jiangsu Lingyun Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 SUANFARMA
  14. 8.3.1 SUANFARMA Company Information
  15. 8.3.2 SUANFARMA Business Overview
  16. 8.3.3 SUANFARMA Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SUANFARMA Veterinary API Manufacturing Product Portfolio
  18. 8.3.5 SUANFARMA Recent Developments
  19. 8.4 Ofichem Group
  20. 8.4.1 Ofichem Group Company Information
  21. 8.4.2 Ofichem Group Business Overview
  22. 8.4.3 Ofichem Group Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ofichem Group Veterinary API Manufacturing Product Portfolio
  24. 8.4.5 Ofichem Group Recent Developments
  25. 8.5 NGL Fine-Chem Ltd.
  26. 8.5.1 NGL Fine-Chem Ltd. Company Information
  27. 8.5.2 NGL Fine-Chem Ltd. Business Overview
  28. 8.5.3 NGL Fine-Chem Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 NGL Fine-Chem Ltd. Veterinary API Manufacturing Product Portfolio
  30. 8.5.5 NGL Fine-Chem Ltd. Recent Developments
  31. 8.6 Menadiona
  32. 8.6.1 Menadiona Company Information
  33. 8.6.2 Menadiona Business Overview
  34. 8.6.3 Menadiona Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Menadiona Veterinary API Manufacturing Product Portfolio
  36. 8.6.5 Menadiona Recent Developments
  37. 8.7 FIS - Fabbrica Italiana Sintetici S.p.A
  38. 8.7.1 FIS - Fabbrica Italiana Sintetici S.p.A Company Information
  39. 8.7.2 FIS - Fabbrica Italiana Sintetici S.p.A Business Overview
  40. 8.7.3 FIS - Fabbrica Italiana Sintetici S.p.A Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 FIS - Fabbrica Italiana Sintetici S.p.A Veterinary API Manufacturing Product Portfolio
  42. 8.7.5 FIS - Fabbrica Italiana Sintetici S.p.A Recent Developments
  43. 8.8 Excel Industries Ltd.
  44. 8.8.1 Excel Industries Ltd. Company Information
  45. 8.8.2 Excel Industries Ltd. Business Overview
  46. 8.8.3 Excel Industries Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Excel Industries Ltd. Veterinary API Manufacturing Product Portfolio
  48. 8.8.5 Excel Industries Ltd. Recent Developments
  49. 8.9 Alivira Animal Health Ltd.
  50. 8.9.1 Alivira Animal Health Ltd. Company Information
  51. 8.9.2 Alivira Animal Health Ltd. Business Overview
  52. 8.9.3 Alivira Animal Health Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Alivira Animal Health Ltd. Veterinary API Manufacturing Product Portfolio
  54. 8.9.5 Alivira Animal Health Ltd. Recent Developments
  55. 8.10 Afton Pharma
  56. 8.10.1 Afton Pharma Company Information
  57. 8.10.2 Afton Pharma Business Overview
  58. 8.10.3 Afton Pharma Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Afton Pharma Veterinary API Manufacturing Product Portfolio
  60. 8.10.5 Afton Pharma Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research